Internal Medicine, Gastroenterology · Houston, TX
NPI
1528051042
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
444 Fm 1959 Rd, Ste A
Houston, TX, 77034
Phone (281) 481-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,360 services
Medicare patients, 2024
294
Average age 72
Drug cost, 2024
$950K
3,500 prescriptions
Company payments, 2025
$2,662
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harry S Ojeas was code 99233 (hospital e&m - subsequent), 124 times for 65 patients. In total Harry S Ojeas billed 1,360 services in 30 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 124 | 65 | $92.59 | $11K |
| 43239 Upper GI Endoscopy | Facility | 75 | 74 | $59.93 | $4,495 |
| 99213 Office E&M - Established | Office | 58 | 46 | $66.18 | $3,838 |
| 99223 Hospital E&M - Initial | Facility | 55 | 54 | $135.79 | $7,468 |
| 45385 Colonoscopy - Lesion Removal | Facility | 47 | 47 | $207.64 | $9,759 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 44 | 11 | $49.93 | $2,197 |
| 99214 Office E&M - Established | Office | 40 | 38 | $86.65 | $3,466 |
| 99204 Office E&M - New | Office | 33 | 33 | $107.05 | $3,533 |
| 99202 Office E&M - New | Office | 25 | 25 | $48.32 | $1,208 |
| 99203 Office E&M - New | Office | 22 | 22 | $65.04 | $1,431 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 20 | 20 | $176.65 | $3,533 |
| 45380 Lower GI Endoscopy - Other | Facility | 17 | 17 | $126.67 | $2,153 |
| 43249 Upper GI Endoscopy | Facility | 15 | 15 | $89.97 | $1,350 |
| 43235 Upper GI Endoscopy | Facility | 13 | 13 | $83.75 | $1,089 |
| 45378 Lower GI Endoscopy - Other | Facility | 11 | 11 | $146.76 | $1,614 |
By year: 2022 $70K for 1,017 services; 2023 $59K for 643 services; 2024 $78K for 1,360 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 97 | 41 | $26.72 | $2,592 |
| 88313 Surgical Pathology Examination | 59 | 23 | $53.83 | $3,176 |
| 88312 Surgical Pathology Examination | 58 | 22 | $67.76 | $3,930 |
Medicare prescription drug claims, 2024
In 2024, the drug Harry S Ojeas prescribed most often to Medicare patients was Omeprazole, with 501 prescriptions and refills. In total Harry S Ojeas wrote 3,500 Medicare prescriptions that cost $950K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 501 | 1,075 | 201 | $5,876 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 387 | 387 | 380 | $21K |
| Famotidine Generic | 337 | 700 | 163 | $4,698 |
| Linzess Linaclotide | 284 | 418 | 105 | $225K |
| Sucralfate Generic | 265 | 331 | 112 | $7,315 |
| Dicyclomine Hcl Generic | 228 | 360 | 121 | $6,131 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 204 | 204 | 200 | $33K |
| Metronidazole Generic | 145 | 145 | 137 | $1,055 |
| Pantoprazole Sodium Generic | 144 | 312 | 62 | $1,254 |
| Amitriptyline Hcl Generic | 93 | 130 | 44 | $842 |
| Esomeprazole Magnesium Generic | 77 | 137 | 35 | $1,594 |
| Ibsrela Tenapanor Hcl | 60 | 84 | 22 | $145K |
| Trulance Plecanatide | 55 | 75 | 18 | $41K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 51 | 51 | 50 | $8,803 |
| Ondansetron Odt Ondansetron | 50 | 50 | 36 | $862 |
Brand drugs: 1,046 claims; generic drugs: 2,454 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harry S Ojeas $2,662 ($2,662 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $752.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 40 | $752 |
| Madrigal Pharmaceuticals MDGL | 20 | $479 |
| Gilead Sciences, Inc. GILD | 11 | $241 |
| Celltrion USA Inc. 068270.KS | 7 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $189 |
| Janssen Biotech, Inc. JNJ | 11 | $189 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 15 | $169 |
| Braintree Laboratories, Inc. | 7 | $160 |
| Ardelyx, Inc. ARDX | 4 | $100 |
| Pfizer Inc. PFE | 2 | $51.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.